Last reviewed · How we verify

Henogen — Portfolio Competitive Intelligence Brief

Henogen pipeline: 0 marketed, 0 filed, 9 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 9 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Adjuvanted Hepatitis B vaccine Lot 2 Adjuvanted Hepatitis B vaccine Lot 2 phase 3
HB-AS02V vaccine HB-AS02V vaccine phase 3 Therapeutic vaccine Hepatitis B surface antigen (HBsAg) Immunology / Virology
Henogen HBV vaccine Henogen HBV vaccine phase 3 Vaccine Hepatitis B surface antigen (HBsAg) Immunology
HB-AS02V HB-AS02V phase 3 Therapeutic vaccine Hepatitis B surface antigen (HBsAg) Immunology / Infectious Disease
Adjuvanted Hep B vaccine Lot 3 Adjuvanted Hep B vaccine Lot 3 phase 3 Vaccine Hepatitis B surface antigen (HBsAg) Immunology
Fendrix vaccine Fendrix vaccine phase 3 Recombinant hepatitis B vaccine with adjuvant Hepatitis B surface antigen (HBsAg) Immunology / Infectious Disease
Adjuvanted Hepatitis B vaccine Lot 1 Adjuvanted Hepatitis B vaccine Lot 1 phase 3 Vaccine Hepatitis B surface antigen (HBsAg) Immunology
Henogen HB vaccine Henogen HB vaccine phase 3 Recombinant hepatitis B vaccine Hepatitis B surface antigen (HBsAg) Immunology / Infectious Disease
HBVAXPRO vaccine HBVAXPRO vaccine phase 3 Recombinant protein vaccine Hepatitis B surface antigen (HBsAg) Immunology / Infectious Disease

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. GlaxoSmithKline · 5 shared drug classes
  2. Pfizer · 2 shared drug classes
  3. ANRS, Emerging Infectious Diseases · 2 shared drug classes
  4. Green Cross Corporation · 2 shared drug classes
  5. Merck Sharp & Dohme LLC · 2 shared drug classes
  6. Bharat Biotech International Limited · 2 shared drug classes
  7. Henry M. Jackson Foundation for the Advancement of Military Medicine · 2 shared drug classes
  8. Sanofi Pasteur, a Sanofi Company · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Henogen:

Cite this brief

Drug Landscape (2026). Henogen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/henogen. Accessed 2026-05-13.

Related